INNOCAN PHARMA CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.169 EUR | -2.59% |
|
+3.85% | -10.09% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 815B | ||||||
| 654B | ||||||
| 354B | - | - | - | - | ||
| 337B | ||||||
| 302B |
